HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children

NCT00978068 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Malaria
HIV Infections

Interventions

DRUG: Lopinavir/Ritonavir (LPV/r)
DRUG: Nevirapine (NVP)
DRUG: Efavirenz (EFV)
DRUG: 2 nucleoside reverse transcriptase inhibitor (NRTI)

Sponsor

University of California, San Francisco

Collaborators

[object Object]